Karen Hynes, Author at Beta Bionics

About Karen Hynes

This author has not written his bio yet.
But we are proud to say that Karen Hynes contributed 33 entries already.

Entries by Karen Hynes

Phase 2a trial results support development of dasiglucagon in the iLet™ pump system for type 1 diabetes

June 22, 2017

Dasiglucagon* is a potential first-in-class glucagon analog for prevention and treatment of low blood sugar in type 1 diabetes using an automated pump system Dasiglucagon was dosed using the iLet™ platform, a state-of-the-art dual-hormone artificial pancreas pump system, administering both glucagon and insulin In the Phase 2a trial, dasiglucagon together with insulin was observed to […]

Zealand initiates Phase IIa clinical trial with dasiglucagon in a dual-hormone artificial pancreas system from Beta Bionics

December 13, 2016

An automated delivery system with both insulin and glucagon holds potential to become a paradigm shift in the treatment of type 1 diabetes In December, Zealand initiated two Phase IIa trials, to test dasiglucagon’s potential in a dual-hormone artificial pancreas system Results from both trials are expected in H1 2017 Copenhagen, 13 December 2016 – Zealand […]

Zealand and Beta Bionics to collaborate on the development of a first-in-class dual-hormonal bionic pancreas system for treatment of people with type 1 diabetes

June 10, 2016

Synergistic match of Beta Bionics’s dual-hormonal, artificial, or bionic, pancreas device platform, the iLet, and Zealand’s novel liquid stable glucagon analog, ZP4207 An automated insulin + glucagon delivery system with integrated continuous blood glucose monitoring and mathematical dosing algorithms offers the potential for a paradigm shift in the treatment of diabetes Expected next step under […]

Beta Bionics is a public benefit corporation.

We are committed to balancing purpose with profit and giving back to society as we fulfill our public benefit mission.

Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/resouces/user-guides, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/resources/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.